Zopanib
Zopanib is Pazopanib, an oral multi-targeted tyrosine kinase inhibitor. It is indicated for advanced renal cell carcinoma and soft tissue sarcoma and works by inhibiting angiogenesis and tumor growth through VEGFR, PDGFR, and related pathways.
Features
| Product Name | Zopanib |
| Generic Name | Pazopanib |
| Formulation | Tablet |
| Available Pack Size | 5X6's , 5X4's |
| Available Strength | 200 mg, 400 mg |